Enzymatic synthesis of pharmacologically relevant chiral sulfoxides by improved CbBVMO variants

Abstract

Baeyer–Villiger monooxygenases (BVMOs) are able to catalyse the asymmetric oxidation of sulfides. This property has made them attractive catalysts for the synthesis of chiral sulfoxide drugs. Here, we have designed and synthesised an exhaustive combinatorial mutant library of the previously identified lansoprazole sulfide monooxygenase CbBVMO_V1. From this synthetic combinatorial mutant library, the best mutant, CbBVMO_V3, was selected with a specific activity of approximately 1 U mg⁻¹ for lansoprazole sulfoxides. We then optimised the reaction conditions of a two-phase system, achieving the enzymatic asymmetric synthesis of (R)-lansoprazole in a space-time yield of 213 g L⁻¹ d⁻¹ and an enantiomeric excess of >99% (R) with no detectable by-products. In addition, CbBVMO_V3 showed higher activity towards other prazole sulfides. These results indicate the potential application of CbBVMO in the chiral sulfoxide drug industry.